Genetic Analysis of Diffuse High-Grade Astrocytomas in Infancy Defines a Novel Molecular Entity

Brain Pathology

Volumn 25, Issue 4, 2015, Pages 409-417

  Gielen, Gerrit H ^a   Gessi, Marco ^a   Buttarelli, Francesca R ^b   Baldi, Caterina ^b   Hammes, Jennifer ^a   Zur Muehlen, Anja ^a   Doerner, Evelyn ^a   Denkhaus, Dorota ^a   Warmuth Metz, Monika ^c   Giangaspero, Felice ^d   Lauriola, Libero ^e   Von Bueren, André O ^f   Kramm, Christof M ^f   Waha, Andreas ^a   Pietsch, Torsten ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e IRCCS NEUROMED   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

Author keywords

ALT; ATRX; glioblastoma; H3F3A; high grade glioma; infants; molecular inversion probe analysis; multiplex ligation probe dependent amplification; pediatric brain tumors; SNORD

Indexed keywords

ATRX PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GLIAL FIBRILLARY ACIDIC PROTEIN; H3F3A PROTEIN; KI 67 ANTIGEN; MICROTUBULE ASSOCIATED PROTEIN 2; OLIG 2 PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN P53; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; ATRX PROTEIN, HUMAN; DNA HELICASE; FGFR1 PROTEIN, HUMAN; HISTONE; NUCLEAR PROTEIN; TELOMERASE;

ADOLESCENT; ALTERNATIVE TELOMERE LENGTHENING FLUORESCENCE IN SITU HYBRIDIZATION; ARTICLE; ASTROCYTOMA; CANCER LOCALIZATION; CHILD; CHROMOSOME 10Q; CHROMOSOME 13Q; CHROMOSOME 14Q; CHROMOSOME 1Q; CHROMOSOME 6Q; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFUSE HIGH GRADE ASTROCYTOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE LOSS; GENE MUTATION; GENETIC ANALYSIS; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; INFANT DISEASE; MALE; MITOSIS RATE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PATHOGENESIS; POINT MUTATION; POSTERIOR FOSSA; PROTEIN DEPLETION; PYROSEQUENCING; BRAIN TUMOR; CHROMOSOME ABERRATION; CLASSIFICATION; GENETICS; METABOLISM; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ASTROCYTOMA; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DNA HELICASES; FEMALE; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; MUTATION; NUCLEAR PROTEINS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; TELOMERASE;

EID: 84931562433     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/bpa.12210     Document Type: Article

References (39)

1. Abedalthagafi M, Phillips JJ, Kim GE, Mueller S, Haas-Kogen DA, Marshall RE, et al (2013) The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas. Mod Pathol 26: 1425-1432.
2. Antonelli M, Buttarelli FR, Arcella A, Nobusawa S, Donofrio V, Oghaki H, Giangaspero F, (2010) Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas. J Neurooncol 5: 209-215.
3. Batra V, Sands SA, Holmes E, Russell Geyer J, Yates A, Becker L, et al (2014) Long-term survival of children less than six years of age enrolled on the CCG-945 phase III trial for newly-diagnosed high-grade glioma: a report from the Children's Oncology Group. Pediatr Blood Cancer 61: 151-157.
4. Bax DA, Mackay A, Little SE, Carvalho D, Viana-Pereira M, Tamber N, et al (2010) A distinct spectrum of copy number aberrations in pediatric high-grade gliomas. Clin Cancer Res 16: 3368-3377.
5. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, et al (2007) Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc Natl Acad Sci U S A 104: 20007-20012.
6. Bondy ML, Scheurer ME, Malmer B, Barnholtz-Sloan JS, Davis FG, Il'yasova D, et al (2008) Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer 113: 1953-1968.
7. Brat DJ, Shehata BM, Castellano-Sanchez A, Hawkins C, Yost RB, Greco C, et al (2007) Congenital glioblastoma: a clinicopathologic and genetic analysis. Brain Pathol 17: 276-281.
8. Dong XY, Guo P, Boyd J, Sun X, Li Q, Zhou W, Dong JT, (2009) Implication of snoRNA U50 in human breast cancer. J Genet Genomics 36: 447-454.
9. Dong XY, Rodriguez C, Guo P, Sun X, Talbot JT, Zhou W, et al (2008) SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. Hum Mol Genet 17: 1031-1042.
10. Gessi M, Abdel Moneim Y, Hammes J, Waha A, Pietsch T, (2014) FGFR1 N546K mutation in a case of papillary glioneuronal tumor (PGNT). Acta Neuropathol 127: 935-936.
11. Gessi M, van de Nes J, Griewank K, Barresi V, Buckland ME, Kirfel J, et al (2014) Absence of TERT promoter mutations in primary melanocytic tumors of the central nervous system. Neuropathol Appl Neurobiol 40: 794-797.
12. Gielen GH, Gessi M, Hammes J, Kramm CM, Waha A, Pietsch T, (2013) H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas. Am J Clin Pathol 139: 345-349.
13. Grundy RG, Wilne SH, Robinson KJ, Ironside JW, Cox T, Chong WK, et al (2010) Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial. Eur J Cancer 46: 120-133.
14. Heaphy CM, de Wilde RF, Jiao Y, Klein AP, Edil BH, Shi C, et al (2011) Altered telomeres in tumors with ATRX and DAXX mutations. Science 333: 425.
15. Homig-Holzel C, Savola S, (2012) Multiplex ligation-dependent probe amplification (MLPA) in tumor diagnostics and prognostics. Diagn Mol Pathol 21: 189-206.
16. Jones DT, Hutter B, Jager N, Korshunov A, Kool M, Warnatz HJ, et al (2013) Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 45: 927-932.
17. Karremann M, Rausche U, Roth D, Kühn A, Pietsch T, Gielen GH, et al (2013) Cerebellar location may predict an unfavourable prognosis in paediatric high-grade glioma. Br J Cancer 109: 844-851.
18. Ko JM, Yau WL, Chan PL, Lung HL, Yang L, Lo PH, et al (2005) Functional evidence of decreased tumorigenicity associated with monochromosome transfer of chromosome 14 in esophageal cancer and the mapping of tumor-suppressive regions to 14q32. Genes Chromosomes Cancer 43: 284-293.
19. Koelsche C, Sahm F, Capper D, Reuss D, Sturm D, Jones DT, et al (2013) Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system. Acta Neuropathol 126: 907-915.
20. Liao J, Yu L, Mei Y, Guarnera M, Shen J, Li R, et al (2010) Small nucleolar RNA signatures as biomarkers for non-small-cell lung cancer. Mol Cancer 9: 198.
21. Liu XY, Gerges N, Korshunov A, Sabha N, Khuong-Quang DA, Fontebasso AM, et al (2012) Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations. Acta Neuropathol 124: 615-625.
22. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, (2007) WHO Classification of Tumours of the Central Nervous System, 4th edn. IARC Press: Lyon.
23. Macy ME, Birks DK, Barton VN, Chan MH, Donson AM, Kleinschmidt-Demasters BK, et al (2012) Clinical and molecular characteristics of congenital glioblastoma. Neuro-Oncol 14: 931-941.
24. Mannoor K, Liao J, Jiang F, (2012) Small nucleolar RNAs in cancer. Biochim Biophys Acta 1826: 121-128.
25. Merchant TE, Pollack IF, Loeffler JS, (2010) Brain tumors across the age spectrum: biology, therapy, and late effects. Semin Radiat Oncol 20: 58-66.
26. Mourtada-Maarabouni M, Pickard MR, Hedge VL, Farzaneh F, Williams GT, (2009) GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28: 195-208.
27. Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, et al (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28: 3061-3068.
28. Pollack IF, Hamilton RL, Finkelstein SD, Campbell JW, Martinez AJ, Sherwin RN, et al (1997) The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Cancer Res 57: 304-309.
29. Reifenberger G, Weber RG, Riehmer V, Kaulich K, Willscher E, Wirth H, et al (2014) Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling. Int J Cancer 135: 1822-1831.
30. Rickert CH, Sträter R, Kaatsch P, Wassmann H, Jürgens H, Dockhorn-Dworniczak B, Paulus W, (2001) Pediatric high-grade astrocytomas show chromosomal imbalances distinct from adult cases. Am J Pathol 158: 1525-1532.
31. Riehmer V, Gietzelt J, Beyer U, Hentschel B, Westphal M, Schackert G, et al (2014) Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma. Genes Chromosomes Cancer 53: 589-605.
32. Sanders RP, Kocak M, Burger PC, Merchant TE, Gajjar A, Broniscer A, (2007) High-grade astrocytoma in very young children. Pediatr Blood Cancer 49: 888-893.
33. Schwartzentruber J, Korshunov A, Liu X-Y, Jones DT, Pfaff E, Jacob K, et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482: 226-231.
34. Song KS, Phi JH, Cho B-K, Wang KC, Lee JY, Kim DG, et al (2010) Long-term outcomes in children with glioblastoma. J Neurosurg Pediatr 6: 145-149.
35. Sturm D, Witt H, Hovestadt V, Khuong-Quang DA, Jones DT, Konermann C, et al (2012) Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 22: 425-437.
36. Tanaka R, Satoh H, Moriyama M, Satoh K, Morishita Y, Yoshida S, et al (2000) Intronic U50 small-nucleolar-RNA (snoRNA) host gene of no protein-coding potential is mapped at the chromosome breakpoint t(3;6)(q27;q15) of human B-cell lymphoma. Genes Cells 5: 277-287.
37. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-9110.
38. Wang Y, Cottman M, Schiffman JD, (2012) Molecular inversion probes: a novel microarray technology and its application in cancer research. Cancer Genet 205: 341-355.
39. Wu G, Diaz AK, Paugh BS, Rankin SL, Ju B, Li Y, et al (2014) The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma. Nat Genet 46: 444-450.